Topotecan - usual
IND 178174 Commercial
Phase 3 small_molecule active
Quick answer
Topotecan - usual for SCLC is a Phase 3 program (small_molecule) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- SCLC
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active